JBM Sets 22 June 2026 Board Meeting to Approve FY2026 Results and Dividend Proposal

Bulletin Express06-05

JBM (Healthcare) Limited has scheduled a board meeting for 22 June 2026 to consider and approve the consolidated results for the financial year ended 31 March 2026. The agenda also includes evaluating a potential final dividend and addressing other routine corporate matters.

The notice, dated 5 June 2026, lists the current board composition as follows: Executive Directors—Mr. Sum Kwong Yip, Derek (Chairman and Chief Executive Officer), Mr. Yim Chun Leung and Dr. Cheng Celine Heung Kwan; Non-executive Directors—Mr. Yeung Kwok Chun, Harry and Professor Xu Hongxi; Independent Non-executive Directors—Mr. Chan Kam Chiu, Simon, Mr. Luk Ting Lung, Alan and Mr. Lau Shut Lee, Tony.

The company secretary for the meeting is Mr. Yu Chun Kau.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment